Open AccessAbstract 72: YAP1 mediates initial survival of alectinib therapy in ALK-rearranged lung cancer via pro-apoptotic protein regulation
Author(s) -
Takeshi Tsuji,
Hiroaki Ozasa,
Wataru Aoki,
Shunsuke Aburaya,
Tomoko Funazo,
Koh Furugaki,
Yasushi Yoshimura,
Hitomi Ajimizu,
Yuto Yasuda,
Takashi Nomizo,
Yuichi Sakamori,
Hironori Yoshida,
Mitsuyoshi Ueda,
Young Hak Kim,
Toyohiro Hirai
Publication year - 2019
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2019-72
Subject(s) - yap1 , alectinib , xiap , cancer research , apoptosis , chemistry , anaplastic lymphoma kinase , oncogene , lung cancer , medicine , programmed cell death , pathology , cell cycle , caspase , biochemistry , transcription factor , malignant pleural effusion , gene